TJX Companies

TJX stock reached a new 52-week low of $125.49, 26% below the year high of $170; it is down 9.66% over the past year and nearly 17% year-to-date. Technical indicators point to oversold conditions, and an InvestingPro fair-value calculation signals possible undervaluation. Operationally, TJX reported better-than-expected Q2 results (adjusted EPS $1.22, revenue $15.2bn, comparable-store sales +4%, adjusted pre-tax profit margin 11.9%), while concerns remain about a slowdown in the Marmaxx segment. Analyst reactions ranged from downgrades and price-target cuts to confirmations and raises, reflecting a mixed assessment of the company's prospects. » More on de.investing.com

Crystal Temptations is recalling chocolate eyeball candy sold under its Crystal Temptations brand at Marshalls, TJ Maxx, HomeGoods and Sierra Trading Post after packaging failed to disclose milk, posing a risk of serious allergic reactions. The product was distributed in multiple states including Arizona, California, New Jersey and Texas. No illnesses have been reported; consumers are advised to destroy the candy and contact Crystal Temptations for a refund, while retailers will not issue returns. » More on cbsnews.com

The TJX Companies shares hit a 52-week low of $131.16 and are currently trading at $131.37, about 23% below the 52-week high of $170 and down 6.97% year-to-date. Technical indicators point to an oversold condition, and eight analysts have raised their earnings estimates. For Q2 of fiscal 2027, TJX reported adjusted earnings of $1.22 per share and revenue of $15.2 billion, both slightly above expectations, with comparable-store sales growth of 4% and an adjusted pre-tax margin of 11.9%. Analyst views are mixed: Jefferies cut to hold (price target $145), Bernstein reiterated outperform ($175) and UBS raised its price target to $198 with a buy rating. » More on de.investing.com